News and Comments

COULD AGENUS VACCINE FOR GLIOBLASTOMA BE ASSIGNED BREAKTHROUGH DESIGNATION?

  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...

AGENUS OFFERS AN INVESTMENT OPPORTUNITY.

  Saturday, September 07, 2013

 More...


Recent Postings


Archive


Tags

ABBVIE (ABBV) TOKAI (TKAOI) Dynavax (DVAX) Herceptin Idenix (IDIX) Illumina (ILMN) Onyx (ONXX) Exelixis (EXEL) Bellicum (BLCM) Theravance Bio Pharma (TBPH) Human Genome Sciences (HGSI) Trastuzumab-DM1 Sangamo (SGMO) NEKTAR (NKTR)) Sequenom (SQNM) RenenxBio (RGNX) PTC Therapeutics (PTCT) NOVOCURE (NVCR) Incyte (INCY) Zerenex SUNESIS PHARMACEUTICALS (SNSS) ADVENTRIX (ANX) Roche (ROCHE) Pluristem (PSTI) ISIS (ISIS) Adaptimmune (ADAP) Auspex (ASPX) Roche (RHHBY) Aimmune Therapeutics (AIMT) Intermune (ITMN) ARCA (ABIO) Abbott Laboratories (ABT) Tysabri AERIE PHARMACEUTICALS Merck (MRK) Ariad (ARIA) Vertex (VRTX) Spike Therapeutics (ONCE) Multiple Myeloma Velcade (bortezomib) Jazz Pharmaceuticals (JAZZ) Advaxis (ADXS) Regeneron (REGN) Intercept (ICPT) AstraZeneca (AZN) KERYX (KERX) NANTKWEST (NK) ARGOS (ARGS) Elan (ELN) Genentech VANDA (VNDA) Intrexon (XON) REGULUS (RGLS) ACADIA (ACAD) SYNTA (SNTA) MODERNA KITE (KITE) GlaxoSmithKline (GSK) Agenus (AGEN Vitae Pharmaceuticals (VTAE) Benlysta (belimumab) ImmunoGen (IMGN) Dendreon (DNDN) Amgen (AMGN) Editas (EDIT) Endometrial Cancer Biogen Idec (BIIB) Ridaforolimus Inovio (INO) Valeant Pharmaceuticals International (VRX) INNOVIVA (INVA) Human Longevity (HLI) Array Pharmaceuticals (ARRY) AGOS (ARGS) Micromet (MITI) galapagos (GLPG) ZALTRAP™ Sanofi-Aventis (SAN) Cytokinetics (CYTK) Gilead (GILD) BIOMARIN (BMRN) Biocryst (BCRX) Alder Biopharmaceuticals (ALDR) Anadys (ANDS) CompuGen (CGEN) Rapamune Alnylam (ALNY) Ionis (IONS) Sarepta (SRPT) OSI (OSIP) Bristol-Myers Squibb (BMY) Prolor Biotech (PBTH) HALOZYME (HALO) Sanofi (SNY) Ziofpharm (ZIOP) Seattle Genetics (SGEN) SERES THERAPEUTICS (MCRB) Telaprevir JUNO (JUNO) Agenus (AGEN) Xoma (XOMA) C4 Therapeutics GUARDIAN HEALTH Prosensa (RNA) Global Cell Therapeutics (GBT) Revlimid (lenolidamide) Galena (GALE) Sanofi (SNA) Mirati Therapeutics (MRTX) Anacor (ANAC) IDERA (IDRA) Theravance (THRX)